Skip to content
10-Q

Quarterly Report

Creative Medical Technology Holdings, Inc. CELZ

0001477932-24-006991

← back to feed
Filed
Nov 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 8, 2024 1.75M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $330.91K
Current Liabilities Q3 2024 · Dec 31, 2023 $371.39K
Total Liabilities Q3 2024 · Sep 30, 2024 $330.91K
Total Liabilities Q3 2024 · Dec 31, 2023 $371.39K
Current Assets Q3 2024 · Sep 30, 2024 $6.33M
Current Assets Q3 2024 · Dec 31, 2023 $10.27M
Total Assets Q3 2024 · Sep 30, 2024 $6.89M
Total Assets Q3 2024 · Dec 31, 2023 $10.72M
Stock Repurchased Q3 2024 · Sep 30, 2023 $191.78K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$6.13M
Stockholders Equity Q3 2024 · Sep 30, 2023 $12.09M
Stockholders Equity Q3 2024 · Jun 30, 2023 $13.73M
Stockholders Equity Q3 2024 · Dec 31, 2022 $15.86M
Sga Expense Q3 2024 · Sep 30, 2023 $531.04K
Sga Expense Q3 2024 · Sep 30, 2023 $2.16M
Rd Expense Q3 2024 · Sep 30, 2023 $992.72K
Rd Expense Q3 2024 · Sep 30, 2023 $1.62M
Net Income Q3 2024 · Sep 30, 2023 −$1.45M
Net Income Q3 2024 · Sep 30, 2023 −$3.61M
Operating Income Q3 2024 · Sep 30, 2023 −$1.54M
Operating Income Q3 2024 · Sep 30, 2023 −$3.85M
Gross Profit Q3 2024 · Sep 30, 2023 $3.6K
Gross Profit Q3 2024 · Sep 30, 2023 $3.6K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $2.4K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $2.4K
Revenue Q3 2024 · Sep 30, 2023 $6K
Revenue Q3 2024 · Sep 30, 2023 $6K